KOD
Kodiak Sciences Inc
NASDAQ · Biotechnology
$23.04
+2.03 (+9.66%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 639.02M | 671.15M | 526.83M |
| Net Income | 3.07M | 3.06M | 2.31M |
| EPS | — | — | — |
| Profit Margin | 0.5% | 0.5% | 0.4% |
| Rev Growth | +2.1% | +18.5% | -6.0% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 226.42M | 203.30M | 203.61M |
| Total Equity | 412.58M | 456.58M | 416.75M |
| D/E Ratio | 0.55 | 0.45 | 0.49 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 3.98M | 4.67M | 3.27M |
| Free Cash Flow | 2.86M | 3.84M | 2.49M |